<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29211218</article-id><article-id pub-id-type="pmc">5701112</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Impact of Myocardial Revascularization Method on Smoking Cessation:
Coronary Artery Bypass Grafting <italic>versus</italic> Percutaneous Coronary
Intervention</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Neves</surname><given-names>Ricardo das</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Avila</surname><given-names>Greicy Kelly</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Fernando de Barros</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>de Sampaio</surname><given-names>Jo&#x000e3;o Augusto Ferraz</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1">
<label>1</label> Cardiovascular Surgery Department of Hospital Santa Lucinda,
Sorocaba, S&#x000e3;o Paulo, Brazil.</aff><aff id="aff2">
<label>2</label> Hospital Unimed, Salto, S&#x000e3;o Paulo, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Ricardo das Neves, Alameda das
D&#x000e1;lias, 370 - Jardim Simus - Sorocaba, SP, Brazil, Zip code: 18055-195.
E-mail: <email>ricardoneves@hotmail.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2017</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2017</year></pub-date><volume>32</volume><issue>5</issue><fpage>383</fpage><lpage>389</lpage><history><date date-type="received"><day>03</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>02</day><month>4</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Smoking is a serious public health issue, being a precursor of heart disease
and a predictor of sudden death due to myocardial ischemia. Major events in
the patient's health can lead to radical changes in habits and the choice
for different myocardial revascularization methods might differently impact
smoking cessation and relapse.</p></sec><sec><title>Objective</title><p>To study the rate and perpetuation of smoking cessation after myocardial
revascularization comparing coronary artery bypass grafting (CABG) and
percutaneous coronary intervention (PCI).</p></sec><sec><title>Methods</title><p>Smokers submitted to myocardial revascularization were divided into CABG and
PCI groups. The research was conducted through interviews at the Hospital
Santa Lucinda outpatient clinic. Patients with smoking cessation longer than
90 days before hospital admission, combined procedures, hospital readmission
before 360 days after discharge, cases of death at any time, and emergency
procedures were excluded from the study. The start of the smoking cessation
period was determined as just after hospital discharge, with a follow-up of
12 months.</p></sec><sec><title>Results</title><p>The proportion of patients reporting smoking relapse was significantly lower
in the CABG than in the PCI group at 30 (11.1% <italic>vs.</italic> 20.8%;
<italic>P</italic>=0.039) and at 180 days (23.1% <italic>vs.</italic>
41.5%; <italic>P</italic>=0.002), but no differences were observed between
the two groups at 360 days after hospital discharge (51.9%
<italic>vs.</italic> 54.1%; <italic>P</italic>=0.719). High levels of
nicotine dependence and passive smoking showed to be important predictors of
smoking relapse in the long-term.</p></sec><sec><title>Conclusion</title><p>The occurrence of a major surgical procedure seems to have beneficial
psychological effects, representing an interesting setting for smoking
cessation counseling to have higher chances of success.</p></sec></abstract><kwd-group><kwd>Myocardial Infarction</kwd><kwd>Myocardial Revascularization</kwd><kwd>Angioplasty, Balloon, Coronary</kwd><kwd>Angioplasty</kwd><kwd>Smoking</kwd><kwd>Tobacco Use Cessation</kwd></kwd-group></article-meta></front><body><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
grafting</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CRP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= C-reactive protein</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">INCA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Instituto Nacional de
C&#x000e2;nce</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PCI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Percutaneous coronary
intervention</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Smoking is a serious public health issue, being a precursor of heart disease and a
predictor of sudden death due to myocardial ischemia<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. According to the Instituto Nacional de
C&#x000e2;ncer (INCA), passive smokers present a 24% higher risk of myocardial
infarction compared to control patients<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Smoking is an of the most important public health problems
characteristic only of the human species. The World Health Organization says that
smoking should be considered a pandemic, as around five million people die each year
as a result of tobacco-related diseases. Of the total deaths occurred, four million
are in the male sex and one million in the female sex. In the year 2025, there will
be 10 million deaths from tobacco use if there is no change in the current
prevalence of smoking. Cigarette kills more than the sum of other preventable causes
of death such as cocaine, heroin, alcohol, fires, suicides and AIDS in developed
countries<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>Smoking cessation is one of the main interventions during the treatment of ischemic
coronary disease. Smoking cessation, alone, results in a reduction of approximately
36% in the risk of death and 32% in the risk of non-fatal myocardial
infarction<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. The success
in quitting cigarette addiction, however, is limited, with success rates varying
from 10% to 25% after one year of smoking cessation<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. According to the literature, coronary artery
bypass grafting (CABG) is an important motivation factor for smoking
cessation<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>Considering the hypothesis that there is a strong association between a major event
in the patient's health and a radical change in habit, the aim of the present study
was to investigate the rate and perpetuation of smoking cessation after two
different myocardial revascularization methods, comparing the findings of CABG and
percutaneous coronary intervention (PCI).</p></sec><sec sec-type="methods"><title>METHODS</title><p>This cross-sectional study was based on data collected at Santa Lucinda Hospital, in
the city of Sorocaba, Brazil. A total of 199 patients underwent CABG surgery and 768
patients underwent PCI, between January 2014 and August 2015. The inclusion
criterion was smoking, independent of the time of addiction, being excluded patients
with smoking cessation for more than 90 days prior to hospital admission, with
combined approach with angioplasty followed by revascularization during
hospitalization, death and rehospitalization in the selected period. After the
selection of patients, the study has 108 patients who underwent CABG and 159
patients who underwent PCI, who were interviewed and submitted to a questionnaire
about nicotine addiction through the Fagerstr&#x000f6;m test, smoking cessation
conditions with 30, 180 and 360 days after hospital discharge, cohabitation with
other smokers, schooling, comorbidities, age, sex, and median income. When
complementation data was helpful, patients were approached by telephone contact.</p><p>Patients were divided into two groups according to the type of revascularization
procedure performed: PCI or CABG. Nicotine dependence was classified according to
score on Fagerstr&#x000f6;m test as very low to medium (1 to 5 points) or high to
very high (6 or more points). Age was categorized as &#x02264;60 or &#x0003e;60 years old.
Monthly income was recorded as a function of the Brazilian minimum wage (R$937.00
(US$287.89) in January 1<sup>st</sup> 2017). Patients living with smokers were
considered to be exposed to passive smoking. The main outcome of the study was
relapse of smoking and determined only by a single cigarette consumed again.</p><p>Data regarding all factors assessed was described for each group (<xref ref-type="table" rid="t1">Table 1</xref>). Number of people relapsing to smoking
was summarized in absolute numbers and cumulative percentages (<xref ref-type="table" rid="t2">Table 2</xref>). Differences between the groups
evaluated were assessed with chi-square tests for categorical data and with t-tests
for continuous data. The occurrence of smoking relapse was presented with
Kaplan-Meier survival curves, and differences in smoking relapse rates between PCI
and CABG groups were evaluated with a log-rank test.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Descriptive analysis of patients undergoing surgical revascularization (CABG)
or percutaneous intervention (PCI).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">CABG</th><th align="center" rowspan="1" colspan="1">PCI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">Mean and standard deviation (years)</td><td align="center" rowspan="1" colspan="1">61.8&#x000b1;8.8</td><td align="center" rowspan="1" colspan="1">65.5&#x000b1;10.1</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">Up to 60 years</td><td align="center" rowspan="1" colspan="1">44 (40.7%)</td><td align="center" rowspan="1" colspan="1">53 (33.3%)</td><td align="center" rowspan="1" colspan="1">0.217</td></tr><tr><td align="left" rowspan="1" colspan="1">Over 60 years</td><td align="center" rowspan="1" colspan="1">64 (59.3%)</td><td align="center" rowspan="1" colspan="1">106 (66.7%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">83 (76.9%)</td><td align="center" rowspan="1" colspan="1">98 (61.6%)</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">25 (23.1%)</td><td align="center" rowspan="1" colspan="1">61 (38.4%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Systemic arterial hypertension</td><td align="center" rowspan="1" colspan="1">60 (55.6%)</td><td align="center" rowspan="1" colspan="1">69 (43.4%)</td><td align="center" rowspan="1" colspan="1">0.051</td></tr><tr><td align="left" colspan="2" rowspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">24 (22.2%)</td><td align="center" rowspan="1" colspan="1">47 (29.6%)</td><td align="center" rowspan="1" colspan="1">0.183</td></tr><tr><td align="left" rowspan="2" colspan="1">Fagerstr&#x000f6;m test</td><td align="left" rowspan="1" colspan="1">Very low to medium</td><td align="center" rowspan="1" colspan="1">83 (76.9%)</td><td align="center" rowspan="1" colspan="1">115 (72.3%)</td><td align="center" rowspan="1" colspan="1">0.407</td></tr><tr><td align="left" rowspan="1" colspan="1">High to very high</td><td align="center" rowspan="1" colspan="1">25 (23.1%)</td><td align="center" rowspan="1" colspan="1">44 (27.7%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Passive smoking</td><td align="center" rowspan="1" colspan="1">12 (11.1%)</td><td align="center" rowspan="1" colspan="1">28 (17.6%)</td><td align="center" rowspan="1" colspan="1">0.144</td></tr><tr><td align="left" rowspan="3" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Middle school</td><td align="center" rowspan="1" colspan="1">69 (63.9%)</td><td align="center" rowspan="1" colspan="1">114 (71.7%)</td><td align="center" rowspan="1" colspan="1">0.393</td></tr><tr><td align="left" rowspan="1" colspan="1">High school</td><td align="center" rowspan="1" colspan="1">26 (24.1%)</td><td align="center" rowspan="1" colspan="1">31 (19.5%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Higher education</td><td align="center" rowspan="1" colspan="1">13 (12.0%)</td><td align="center" rowspan="1" colspan="1">14 (8.8%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="3" colspan="1">Average income</td><td align="left" rowspan="1" colspan="1">1-2 minimum wages</td><td align="center" rowspan="1" colspan="1">59 (54.6%)</td><td align="center" rowspan="1" colspan="1">97 (61.0%)</td><td align="center" rowspan="1" colspan="1">0.520</td></tr><tr><td align="left" rowspan="1" colspan="1">2-3 minimum wages</td><td align="center" rowspan="1" colspan="1">36 (33.3%)</td><td align="center" rowspan="1" colspan="1">43 (27.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;3 minimum wages</td><td align="center" rowspan="1" colspan="1">13 (12.0%)</td><td align="center" rowspan="1" colspan="1">19 (11.9%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>CABG=coronary artery bypass grafting; PCI=percutaneous coronary
intervention</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Relapse to smoking in patients undergoing surgical revascularization (CABG)
or percutaneous intervention (PCI).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">CABG</th><th align="center" rowspan="1" colspan="1">PCI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">30 days</td><td align="center" rowspan="1" colspan="1">12 (11.1%)</td><td align="center" rowspan="1" colspan="1">33 (20.8%)</td><td align="center" rowspan="1" colspan="1">0.039</td></tr><tr><td align="left" rowspan="1" colspan="1">180 days</td><td align="center" rowspan="1" colspan="1">25 (23.1%)</td><td align="center" rowspan="1" colspan="1">66 (41.5%)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">360 days</td><td align="center" rowspan="1" colspan="1">56 (51.9%)</td><td align="center" rowspan="1" colspan="1">86 (54.1%)</td><td align="center" rowspan="1" colspan="1">0.719</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>CABG=coronary artery bypass grafting; PCI=percutaneous coronary
intervention</p></fn></table-wrap-foot></table-wrap><p>Logistic regression models were applied for identifying factors associated with
smoking relapse at each time point of the study: 30, 180 and 360 days. Initially the
association between the assessed factors and smoking cessation was assessed in
univariate models (<xref ref-type="table" rid="t3">Table 3</xref>). Subsequently,
all factors associated with smoking cessation with a <italic>P</italic>-value
&#x0003c;0.250 on the univariate models were included in multivariate models. Stepwise
backward elimination was applied for selection of the best fitting model. The final
model was restricted to variables with <italic>P</italic>-values &#x0003c;0.05 in the
multivariate analyses (<xref ref-type="table" rid="t4">Table 4</xref>). Interaction
between the evaluated factors was assessed by adding interaction terms to the
models. If significant interactions were observed, stratified analyses were
performed to better explore each observed interaction.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Univariate logistic regression model.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="2">&#x000a0;</th><th align="center" colspan="3" rowspan="1">30 days</th><th align="center" colspan="3" rowspan="1">180 days</th><th align="center" colspan="3" rowspan="1">360 days</th></tr><tr><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Procedure</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">PCI</td><td align="center" rowspan="1" colspan="1">2.10</td><td align="center" rowspan="1" colspan="1">1.03-4.27</td><td align="center" rowspan="1" colspan="1">0.042</td><td align="center" rowspan="1" colspan="1">2.36</td><td align="center" rowspan="1" colspan="1">1.36-4.07</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">1.09</td><td align="center" rowspan="1" colspan="1">0.67-1.79</td><td align="center" rowspan="1" colspan="1">0.719</td></tr><tr><td align="left" rowspan="2" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">Up to 60 years</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Over 60 years</td><td align="center" rowspan="1" colspan="1">5.66</td><td align="center" rowspan="1" colspan="1">2.15-14.89</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">0.68-1.97</td><td align="center" rowspan="1" colspan="1">0.580</td><td align="center" rowspan="1" colspan="1">1.26</td><td align="center" rowspan="1" colspan="1">0.77-2.08</td><td align="center" rowspan="1" colspan="1">0.361</td></tr><tr><td align="left" rowspan="2" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">1.35</td><td align="center" rowspan="1" colspan="1">0.69-2.62</td><td align="center" rowspan="1" colspan="1">0.382</td><td align="center" rowspan="1" colspan="1">1.23</td><td align="center" rowspan="1" colspan="1">0.72-2.10</td><td align="center" rowspan="1" colspan="1">0.458</td><td align="center" rowspan="1" colspan="1">1.09</td><td align="center" rowspan="1" colspan="1">0.65-1.83</td><td align="center" rowspan="1" colspan="1">0.740</td></tr><tr><td align="left" colspan="2" rowspan="1">SAH</td><td align="center" rowspan="1" colspan="1">1.42</td><td align="center" rowspan="1" colspan="1">0.75-2.70</td><td align="center" rowspan="1" colspan="1">0.288</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">0.43-1.19</td><td align="center" rowspan="1" colspan="1">0.200</td><td align="center" rowspan="1" colspan="1">0.91</td><td align="center" rowspan="1" colspan="1">0.56-1.47</td><td align="center" rowspan="1" colspan="1">0.693</td></tr><tr><td align="left" colspan="2" rowspan="1">DM</td><td align="center" rowspan="1" colspan="1">0.46</td><td align="center" rowspan="1" colspan="1">0.19-1.07</td><td align="center" rowspan="1" colspan="1">0.071</td><td align="center" rowspan="1" colspan="1">0.90</td><td align="center" rowspan="1" colspan="1">0.51-1.61</td><td align="center" rowspan="1" colspan="1">0.726</td><td align="center" rowspan="1" colspan="1">1.19</td><td align="center" rowspan="1" colspan="1">0.69-2.05</td><td align="center" rowspan="1" colspan="1">0.534</td></tr><tr><td align="left" rowspan="2" colspan="1">Fagerstr&#x000f6;m test</td><td align="left" rowspan="1" colspan="1">Very low to medium</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">High to very high</td><td align="center" rowspan="1" colspan="1">2.51</td><td align="center" rowspan="1" colspan="1">1.29-4.91</td><td align="center" rowspan="1" colspan="1">0.007</td><td align="center" rowspan="1" colspan="1">13.95</td><td align="center" rowspan="1" colspan="1">7.20-27.03</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">6.32</td><td align="center" rowspan="1" colspan="1">3.19-12.50</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" colspan="2" rowspan="1">Passive smoking</td><td align="center" rowspan="1" colspan="1">0.36</td><td align="center" rowspan="1" colspan="1">0.11-1.21</td><td align="center" rowspan="1" colspan="1">0.099</td><td align="center" rowspan="1" colspan="1">1,95</td><td align="center" rowspan="1" colspan="1">0.99-3.85</td><td align="center" rowspan="1" colspan="1">0.055</td><td align="center" rowspan="1" colspan="1">4.26</td><td align="center" rowspan="1" colspan="1">1.88-9.63</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="3" colspan="1">Education</td><td align="left" rowspan="1" colspan="1">Middle school</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">High school</td><td align="center" rowspan="1" colspan="1">0.79</td><td align="center" rowspan="1" colspan="1">0.36-1.77</td><td align="center" rowspan="1" colspan="1">0.570</td><td align="center" rowspan="1" colspan="1">1.03</td><td align="center" rowspan="1" colspan="1">0.55-1.92</td><td align="center" rowspan="1" colspan="1">0.927</td><td align="center" rowspan="1" colspan="1">1.34</td><td align="center" rowspan="1" colspan="1">0.73-2.45</td><td align="center" rowspan="1" colspan="1">0.342</td></tr><tr><td align="left" rowspan="1" colspan="1">Higher education</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="center" rowspan="1" colspan="1">0.02-1.24</td><td align="center" rowspan="1" colspan="1">0.08</td><td align="center" rowspan="1" colspan="1">0.80</td><td align="center" rowspan="1" colspan="1">0.33-1.94</td><td align="center" rowspan="1" colspan="1">0.623</td><td align="center" rowspan="1" colspan="1">0.73</td><td align="center" rowspan="1" colspan="1">0.32-1.63</td><td align="center" rowspan="1" colspan="1">0.438</td></tr><tr><td align="left" rowspan="3" colspan="1">Average income</td><td align="left" rowspan="1" colspan="1">1-2 minimum wages</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">2-3 minimum wages</td><td align="center" rowspan="1" colspan="1">0.65</td><td align="center" rowspan="1" colspan="1">0.31-1.38</td><td align="center" rowspan="1" colspan="1">0.263</td><td align="center" rowspan="1" colspan="1">0.74</td><td align="center" rowspan="1" colspan="1">0.41-1.32</td><td align="center" rowspan="1" colspan="1">0.302</td><td align="center" rowspan="1" colspan="1">0.72</td><td align="center" rowspan="1" colspan="1">0.42-1.23</td><td align="center" rowspan="1" colspan="1">0.228</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e;3 minimum wages</td><td align="center" rowspan="1" colspan="1">0.42</td><td align="center" rowspan="1" colspan="1">0.12-1.46</td><td align="center" rowspan="1" colspan="1">0.171</td><td align="center" rowspan="1" colspan="1">0.66</td><td align="center" rowspan="1" colspan="1">0.29-1.53</td><td align="center" rowspan="1" colspan="1">0.332</td><td align="center" rowspan="1" colspan="1">0.77</td><td align="center" rowspan="1" colspan="1">0.36-1.66</td><td align="center" rowspan="1" colspan="1">0.507</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>CABG=coronary artery bypass grafting; CI=confidence interval; DM=diabetes
mellitus; OR=odds ratio; PCI=percutaneous coronary intervention;
SAH=systemic arterial hypertension</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Multivariate logistic regression model.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/><col width="9%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="2">&#x000a0;</th><th align="center" colspan="3" rowspan="1">30 days</th><th align="center" colspan="3" rowspan="1">180 days</th><th align="center" colspan="3" rowspan="1">360 days</th></tr><tr><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Procedure</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">PCI</td><td align="center" rowspan="1" colspan="1">2.15</td><td align="center" rowspan="1" colspan="1">1.00-4.62</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">2.84</td><td align="center" rowspan="1" colspan="1">1.46-5.51</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">Up to 60 years</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Over 60 years</td><td align="center" rowspan="1" colspan="1">7.85</td><td align="center" rowspan="1" colspan="1">2.77-22.21</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">DM</td><td align="center" rowspan="1" colspan="1">0.39</td><td align="center" rowspan="1" colspan="1">0.15-1.00</td><td align="center" rowspan="1" colspan="1">0.05</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="2" colspan="1">Fagerstr&#x000f6;m test</td><td align="left" rowspan="1" colspan="1">Very low to medium</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">High to very high</td><td align="center" rowspan="1" colspan="1">4.17</td><td align="center" rowspan="1" colspan="1">1.93-9.00</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">15.23</td><td align="center" rowspan="1" colspan="1">7.62-30.43</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" rowspan="1" colspan="1">7.32</td><td align="center" rowspan="1" colspan="1">3.53-15.18</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" colspan="2" rowspan="1">Passive smoking</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">4.69</td><td align="center" rowspan="1" colspan="1">1.93-11.40</td><td align="center" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>CABG=coronary artery bypass grafting; CI=confidence interval; DM=diabetes
mellitus; OR=odds ratio; PCI=percutaneous coronary intervention</p></fn></table-wrap-foot></table-wrap><p>The present study was approved by the research ethics committee of
Funda&#x000e7;&#x000e3;o S&#x000e3;o Paulo - PUC-SP Sorocaba campus and the
participating patients provided written informed consent. Data were analyzed with
IBM SPSS software version 24 (IBM, New York, USA) and GraphPad Prism 5 (GraphPad
Software Inc., La Jolla, USA). All tests were two-sided and
<italic>P</italic>-values lower than 0.05 were considered as statistically
significant.</p></sec><sec sec-type="results"><title>RESULTS</title><p>In total, 159 patients who had PCI and 108 patients who had CABG were included. The
characteristics of the patients and the procedures, as well as the variables
analyzed in the study, are presented in <xref ref-type="table" rid="t1">Table
1</xref>. Patients from the PCI group were significantly older than those from
the CABG group (65.5&#x000b1;10.1 <italic>vs.</italic> 61.8&#x000b1;8.8). The gender
distribution was also significantly different between the two groups, with 76.9% of
males in the CABG group and 61.6% of males in the PCI group. The prevalence of
systemic diseases (systemic arterial hypertension and diabetes mellitus), the level
of dependence to nicotine according to the Fagerstr&#x000f6;m score, exposure to
passive smoking, education level and monthly income were not significantly different
between patients who had CABG or PCI.</p><p>The proportion of patients reporting smoking relapse was significantly lower in the
CABG than in the PCI group at 30 (11.1% <italic>vs.</italic> 20.8%) and at 180 days
(23.1% <italic>vs.</italic> 41.5%), but no differences were observed between the two
groups at 360 days after hospital discharge (<xref ref-type="table" rid="t2">Table
2</xref>). The occurrence of smoking relapse in patients who had CABG and in
those who had PCI was visualized with Kaplan-Meier survival curves (<xref ref-type="fig" rid="f1">Figure 1</xref>). No significant differences on the
occurrence of smoking relapse between the two groups was observed with the log-rank
test (<italic>P</italic>-value=0.238).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Kaplan-Meier curves for the maintenance of smoking cessation (log-rank
test, P=0.238). CABG=coronary artery bypass grafting; PCI=percutaneous
coronary intervention</p></caption><graphic xlink:href="rbccv-32-05-0383-g01"/></fig>
</p><p>Univariate logistic regression models indicated that the type of revascularization
procedure was significantly associated with smoking relapse at 30 and at 180 days
after hospital discharge, with patients from the PCI group being more likely to
relapse smoking than patients from the CABG group (OR: 2.10, 95% CI: 1.03-4.27 and
OR: 2.36, 95% CI: 1.36-4.07, respectively). At 360 days no association between type
of revascularization and hospital discharge was observed.</p><p>Older age (&#x0003e;60 years old) was associated with a higher rate of smoking relapse 30
days after hospital discharge (OR: 5.66, 95% CI: 2.15-14.89), but not at later
follow-up assessments. High levels of nicotine dependence assessed by the
Fagerstr&#x000f6;m score were associated with the occurrence of smoking relapse at
all time points of the study (OR: 2.51, 95% CI: 1.29-4.91; OR: 13.95, 95% CI:
7.20-27.03 and OR: 6.32, 95% CI: 3.19-12.50 at 30, 180 and 360 days respectively).
Passive smoking was not a significant predictor of smoking relapse at 30 and 180
days, but it was associated to smoking relapse at 360 days after hospital discharge
(OR: 4.26, 95% CI: 1.88-9.63).</p><p>Multivariate logistic regression revealed that the association between type of
revascularization procedure (CABG or PCI) and smoking relapse at 30 and 180 days was
still observed even when taking possible confounders into account (OR: 2.15, 95% CI:
1,00-4,62 at 30 days and OR: 2.84, 95% CI: 1,46-5,51 at 180 days). The association
between level of nicotine dependence and smoking relapse also remained significant,
at all time points, after taking possible confounders into account (OR: 4.17, 95%
CI: 1.93-9.00; OR: 15.23, 95% CI: 7.62-30.43 and OR: 7.32, 95% CI: 3.53-15.18 at 30,
180 and 360 days, respectively).</p><p>Significant interactions between the type of revascularization procedure and
Fagerstr&#x000f6;m score was observed in the multivariate models for 30 and 180 days
of follow-up, while in the model for 360 days of follow-up a significant interaction
between Fagerstr&#x000f6;m score and passive smoking was observed. In order to better
explore these interactions, additional analyses were performed, stratifying the
cohort according to the variables between which interaction was observed.</p><p>At 30 days of follow-up, the type of intervention was significantly associated with
smoking relapse among patients with high Fagerstr&#x000f6;m scores (OR: 6.78, 95% CI:
1.52-30.25), but not among those with low Fagerstr&#x000f6;m scores. On the other
hand, Fagerstr&#x000f6;m score was associated with smoking relapse among patients
with PCI (OR: 7.16, 95% CI: 2.61-19.59), but not among those who had CABG. At 60
days of follow-up, similar results were observed when stratifying patients according
to Fagerstr&#x000f6;m score, with type of intervention being associated with smoking
relapse only among patients with high Fagerstr&#x000f6;m scores (OR: 9.23, 95% CI:
2.53-33.64). When stratifying patients according to type of intervention, however, a
significant association between Fagerstr&#x000f6;m score and smoking relapse was
observed in both groups (OR: 6.41, 95% CI: 2,37-17,33 for CABG and OR: 34.23, 95%
CI: 11.20-104.58 for PCI). At 360 days of follow-up, a correlation between
Fagerstr&#x000f6;m score and smoking relapse was only observed among patients not
exposed to passive smoking (OR: 8.0, 95% CI: 3,67-17,45), while passive smoking was
only associated with smoking relapse among patients with low/moderate dependence to
nicotine according to Fagerstr&#x000f6;m test (<xref ref-type="table" rid="t5">Tables
5</xref> and <xref ref-type="table" rid="t6">6</xref>).</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Stratified analysis of the interaction between variables "Procedure" and
"Fagerstr&#x000f6;m test" in the relapse of smoking.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><tbody><tr><td align="left" colspan="2" rowspan="2"><bold>30 days</bold></td><td align="center" colspan="2" rowspan="1"><bold>Fagerstr&#x000f6;m test</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Very low to medium</bold></td><td align="center" rowspan="1" colspan="1"><bold>High to very high</bold></td><td align="center" rowspan="1" colspan="1"><bold>OR</bold></td><td align="center" rowspan="1" colspan="1"><bold>95% CI</bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr><tr><td align="left" rowspan="2" colspan="1">Procedure</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="center" rowspan="1" colspan="1">9/83 (10.8%)</td><td align="center" rowspan="1" colspan="1">3/25 (12%)</td><td align="center" rowspan="1" colspan="1">1.36</td><td align="center" rowspan="1" colspan="1">0.31-6.00</td><td align="center" rowspan="1" colspan="1">0.683</td></tr><tr><td align="left" rowspan="1" colspan="1">PCI</td><td align="center" rowspan="1" colspan="1">17/115 (14.8%)</td><td align="center" rowspan="1" colspan="1">16/44 (36.4%)</td><td align="center" rowspan="1" colspan="1">7.16</td><td align="center" rowspan="1" colspan="1">2.61-19.59</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">OR</td><td align="center" rowspan="1" colspan="1">1.16</td><td align="center" rowspan="1" colspan="1">6.78</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">0.47-2.86</td><td align="center" rowspan="1" colspan="1">1.52-30.25</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.749</td><td align="center" rowspan="1" colspan="1">0.012</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="2"><bold>180 days</bold></td><td align="center" colspan="2" rowspan="1"><bold>Fagerstr&#x000f6;m test</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td><td align="center" rowspan="1" colspan="1"><bold>&#x000a0;</bold></td></tr><tr><td align="center" rowspan="1" colspan="1"><bold>Very low to medium</bold></td><td align="center" rowspan="1" colspan="1"><bold>High to very high</bold></td><td align="center" rowspan="1" colspan="1"><bold>OR</bold></td><td align="center" rowspan="1" colspan="1"><bold>95% CI</bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr><tr><td align="left" rowspan="2" colspan="1">Procedure</td><td align="left" rowspan="1" colspan="1">CABG</td><td align="center" rowspan="1" colspan="1">12/83 (14.5%)</td><td align="center" rowspan="1" colspan="1">13/25 (52%)</td><td align="center" rowspan="1" colspan="1">6.41</td><td align="center" rowspan="1" colspan="1">2.37-17.33</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">PCI</td><td align="center" rowspan="1" colspan="1">23/115 (22.6%)</td><td align="center" rowspan="1" colspan="1">40/44 (90.9%)</td><td align="center" rowspan="1" colspan="1">34.23</td><td align="center" rowspan="1" colspan="1">11.20-104.58</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">OR</td><td align="center" rowspan="1" colspan="1">1.73</td><td align="center" rowspan="1" colspan="1">9.23</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">0.82-3.67</td><td align="center" rowspan="1" colspan="1">2.53-33.64</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.154</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>CABG=coronary artery bypass grafting; CI=confidence interval; OR=odds
ratio; PCI=percutaneous coronary intervention</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Stratified analysis of the interaction between variables "Passive smoking"
and "Fagerstr&#x000f6;m test" in the relapse of smoking.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="2">360 days</th><th align="center" colspan="2" rowspan="1">Fagerstr&#x000f6;m test</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr><th align="center" rowspan="1" colspan="1">Very low to medium</th><th align="center" rowspan="1" colspan="1">High to very high</th><th align="center" rowspan="1" colspan="1">OR</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Passive smoking</td><td align="left" rowspan="1" colspan="1">no</td><td align="center" rowspan="1" colspan="1">66/174 (37.9%)</td><td align="center" rowspan="1" colspan="1">44/53 (83%)</td><td align="center" rowspan="1" colspan="1">8.00</td><td align="center" rowspan="1" colspan="1">3.67-17.45</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">yes</td><td align="center" rowspan="1" colspan="1">19/24 (79.2%)</td><td align="center" rowspan="1" colspan="1">13/16 (81.3%)</td><td align="center" rowspan="1" colspan="1">1.14</td><td align="center" rowspan="1" colspan="1">0.23-5.62</td><td align="center" rowspan="1" colspan="1">0.872</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">OR</td><td align="center" rowspan="1" colspan="1">6.2</td><td align="center" rowspan="1" colspan="1">0.89</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1">95% CI</td><td align="center" rowspan="1" colspan="1">2.22-17.45</td><td align="center" rowspan="1" colspan="1">0.21-3.76</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="left" rowspan="1" colspan="1"><italic>P</italic></td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.870</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>CI=confidence interval; OR=odds ratio</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The present study addressed the hypothesis that there is a strong association between
a major event in the patient's health and a radical change in habit, in this case
smoking. We investigated the rate and perpetuation of smoking cessation after two
different myocardial revascularization methods: CABG and PCI. Our results showed
that the number of patients reporting smoking relapse was significantly lower in the
CABG than in the PCI group up to 180 days of follow-up, but no differences were
observed at 360 days after hospital discharge. Furthermore, although CABG
represented a factor for smoking cessation in the short-term, high levels of
nicotine dependence and passive smoking showed to be important predictors of smoking
relapse in the long-term.</p><p>This study also showed an interaction between the myocardial revascularization method
and the Fagerstr&#x000f6;m score, in such a way that in patients with low levels of
nicotine dependence, the procedure of choice has no significant impact on smoking
cessation. This might be related to the fact that, in this group, most patients
cease smoking regardless of the revascularization method, while in the group of
patients with high levels of nicotine dependence mostly those undergoing CABG cease
smoking and the ones subjected to PCI continue or relapse smoking.</p><p>Another interesting interaction found in the present study was between the
Fagerstr&#x000f6;m score and passive smoking. Our results suggest that in patients
with low levels of nicotine dependence, passive smoking is related to a higher rate
of relapse, while in patients with high levels of nicotine dependence passive
smoking does not affect the maintenance of smoking cessation. For these patients,
the rate of relapse is high regardless of the presence of a family member who also
smokes, while for those, mostly the ones exposed to passive smoking will relapse
smoking.</p><p>One limitation of the current study was that patients indicated to different
revascularization procedures may also present different symptomatology, which could
differently impact their predisposition to quit smoking and maintain smoking
cessation. Future studies should take this variable into consideration. On the other
hand, some of the strengths of the present study were its prospective nature and the
long follow-up period. These two characteristics increase the reliability and
validity of our findings.</p><p>Association between the procedure invasiveness and smoking cessation was also
observed in another study with patients treated for coronary artery disease, in
which a higher rate of smoking cessation was observed after surgical
revascularization (55%) than after percutaneous intervention (25%) or angiography
alone (14%) one year after the procedure<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup>. A second study revealed comparable high rates of smoking
cessation following surgical revascularization both at 60 days (93.15%) and 90 days
(93.84%) after the procedure<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.
However, the proportion of patients who relapse 12 months after quitting smoking was
similar in the percutaneous (53.4%) and surgical (52.7%) groups<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Several investigations through the
past 15 years reported similar abstinence rates, with approximately 40% of smoking
cessation maintenance at 12 months after myocardial infarction followed by elective
surgical revascularization and 55.4% after percutaneous coronary
intervention<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>.</p><p>Although patients submitted to major surgeries present a higher probability of
succeeding on smoking cessation in the short-term, when compared to those undergoing
a procedure in an outpatient setting, both this study and the literature show that
this difference does not remain over time. An interesting alternative to potentiate
the beneficial psychological effects of a major surgical procedure is the
combination with counseling during hospitalization or at the time of surgical
intervention, what was previously described as a teaching moment<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. This way, an early intervention
during hospital stay, could present a high possibility of success in smoking
cessation<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.
Furthermore, if counseling is possible to be started a reasonable time before the
intervention, it is also associated with lower rates of postoperative complications,
as observed in a meta-analysis that revealed a 40% reduction in the relative risk of
total complications with preoperative smoking cessation<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref>]</sup>.</p><p>Cigarette smoking represents a complex problem with significant implications for
cardiovascular diseases and, although the prevalence of smoking decreased in the
past 45 years, smoking cessation rates (defined as 6 months of tobacco abstinence)
has been estimated at only 6% in recent years<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>.Cigarette smoking contributes to cardiovascular diseases
in several ways. The toxic products of cigarette circulate in the bloodstream,
increasing the inflammatory response and interfering with the function of the
endothelium and causing abnormalities that lead to the development of
atherosclerotic lesions on the arterial wall. This leads to the narrowing of blood
vessels, gradually impairing blood flow, as well as makes the arteries stiffer, less
elastic and prone to rupture<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>.
Over time, it is possible to observe a progressively impaired vasomotor reactivity
in smokers, as well as platelet dysfunction. Previous studies have described the
correlation between smoking and increased levels of C-reactive protein (CRP),
fibrinogen and homocysteine. Furthermore, smoking increases the inflammatory
response, which in association with higher levels of homocysteine can represent an
important mechanism of atherosclerosis development<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.</p><p>Smoking cessation can reduce the progression of arterial disease, the risk of
myocardial infarction, and the mortality due to cardiovascular diseases in more than
one third, surpassing other preventive treatments<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. When smokers are hospitalized they can be more
prone to accept interventions for smoking cessation<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, but individual characteristics, such as level of
addiction to nicotine and contact with other smokers, are potential factors of
failure<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Still,
smoking cessation programs should be strongly encouraged for patients undergoing
surgical procedures<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>The present study showed that, in the short-term, the number of patients reporting
smoking relapse was significantly lower among those undergoing CABG than in the
group subjected to PCI in the short-term. However, in the long-term, this difference
did not remain. High levels of nicotine dependence and passive smoking showed to be
important predictors of smoking relapse. Still, the occurrence of a major surgical
procedure seems to be a special setting for smoking cessation guidance to have
higher chances of success. Further studies, combining counseling with the surgical
intervention, should be performed to evaluate this scenario.</p><table-wrap id="t8" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" valign="top" rowspan="1">Authors' roles &#x00026;
responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">RN</td><td align="left" valign="top" rowspan="1" colspan="1">Conception of the work; acquisition,
analysis and interpretation of data for the work; revising; final
approval of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GKA</td><td align="left" valign="top" rowspan="1" colspan="1">Conception and design of the work;
manuscript redaction or critical review of its content; final
approval of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FBO</td><td align="left" valign="top" rowspan="1" colspan="1">Acquisition and analysis of data; final
approval of the manuscript version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JAFS</td><td align="left" valign="top" rowspan="1" colspan="1">Acquisition and analysis of data; final
approval of the manuscript version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Hospital Santa Lucinda, Sorocaba, S&#x000e3;o
Paulo, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>JP</given-names></name><name><surname>Bitterman</surname><given-names>H</given-names></name></person-group><article-title>Nicotine and angiogenesis: a new paradigm for tobacco-related
diseases</article-title><source>Ann Med</source><year>2004</year><volume>36</volume><issue>1</issue><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">15000345</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Instituto Nacional do Cancer</collab></person-group><source>Programa Nacional de Controle do Tabagismo</source><comment>Available_from:_<ext-link ext-link-type="uri" xlink:href="http://www2.inca.gov.br/ps/wcm/connect/acoes_programas/site/home/nobrasil/programa-nacional-controle-tabagismo/tabagismo">http://www2.inca.gov.br/ps/wcm/connect/acoes_programas/site/home/nobrasil/programa-nacional-controle-tabagismo/tabagismo</ext-link></comment></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>AJ</given-names></name><name><surname>Menezes</surname><given-names>AMB</given-names></name><name><surname>D&#x000f3;rea</surname><given-names>AJPS</given-names></name><name><surname>Torres</surname><given-names>BS</given-names></name><name><surname>Viegas</surname><given-names>CAA</given-names></name><name><surname>Silva</surname><given-names>CAR</given-names></name><etal/></person-group><article-title>Diretrizes para cessa&#x000e7;&#x000e3;o do
tabagismo</article-title><source>J Bras Pneumol</source><year>2004</year><volume>30</volume><issue>Suppl 2</issue><fpage>S1</fpage><lpage>76</lpage></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Critchley</surname><given-names>JA</given-names></name><name><surname>Capewell</surname><given-names>S</given-names></name></person-group><article-title>Mortality risk reduction associated with smoking cessation in
patients with coronary heart disease: a systematic review.</article-title><source>JAMA</source><comment>[online]</comment><year>2003</year><volume>290</volume><issue>1</issue><fpage>86</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">12837716</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barth</surname><given-names>J</given-names></name><name><surname>Critchley</surname><given-names>J</given-names></name><name><surname>Bengel</surname><given-names>J</given-names></name></person-group><article-title>Efficacy of psychosocial interventions for smoking cessation in
patients with coronary heart disease: a systematic review and
meta-analysis</article-title><source>Ann Behav Med</source><year>2006</year><volume>32</volume><issue>1</issue><fpage>10</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16827625</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>RC</given-names></name><name><surname>Barbisan</surname><given-names>JN</given-names></name></person-group><article-title>Impact of coronary artery bypass graft surgery in smoking
cessation</article-title><source>Rev Bras Cir Cardiovasc</source><year>2010</year><volume>25</volume><issue>1</issue><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">20563472</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rallidis</surname><given-names>LS</given-names></name><name><surname>Lekakis</surname><given-names>J</given-names></name><name><surname>Panagiotakos</surname><given-names>D</given-names></name><name><surname>Fountoulaki</surname><given-names>K</given-names></name><name><surname>Komporozos</surname><given-names>C</given-names></name><name><surname>Apostolou</surname><given-names>T</given-names></name><etal/></person-group><article-title>Long-term prognostic factors of young patients (&#x02264;35 years)
having acute myocardial infarction: the detrimental role of continuation of
smoking</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2008</year><volume>15</volume><issue>5</issue><fpage>567</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">18769343</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saksens</surname><given-names>NT</given-names></name><name><surname>Noyez</surname><given-names>L</given-names></name></person-group><article-title>Smoking behaviour and attitudes in patients undergoing cardiac
surgery. The Radboud experience</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2010</year><volume>10</volume><issue>2</issue><fpage>195</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">19884164</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammal</surname><given-names>F</given-names></name><name><surname>Ezekowitz</surname><given-names>JA</given-names></name><name><surname>Norris</surname><given-names>CM</given-names></name><name><surname>Wild</surname><given-names>TC</given-names></name><name><surname>Finegan</surname><given-names>BA</given-names></name><collab>APPROACH Investigators</collab></person-group><article-title>Smoking status and survival: impact on mortality of continuing to
smoke one year after the angiographic diagnosis of coronary artery disease,
a prospective cohort study</article-title><source>BMC Cardiovasc Disord.</source><year>2014</year><volume>14</volume><fpage>133</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">25274407</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>TV</given-names></name><name><surname>Rudnicki</surname><given-names>M</given-names></name><name><surname>Franco</surname><given-names>RF</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name></person-group><article-title>Effect of the G-308A polymorphism of the tumor necrosis factor
alpha gene on the risk of ischemic heart disease and ischemic stroke: a
meta-analysis</article-title><source>Am Heart J</source><year>2007</year><volume>153</volume><issue>5</issue><fpage>821</fpage><lpage>830</lpage><pub-id pub-id-type="pmid">17452160</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghbeli</surname><given-names>N</given-names></name><name><surname>Kirtane</surname><given-names>AJ</given-names></name><name><surname>Ray</surname><given-names>KK</given-names></name><name><surname>Murphy</surname><given-names>SA</given-names></name><name><surname>Gibson</surname><given-names>CM</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><etal/></person-group><article-title>C-reactive protein and cardiovascular outcomes in smokers versus
nonsmokers in non-ST-elevation acute coronary syndrome (from the
TACTICS-TIMI 18 trial)</article-title><source>Am J Cardiol</source><year>2005</year><volume>96</volume><issue>5</issue><fpage>635</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">16125484</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilbert</surname><given-names>JJ</given-names></name></person-group><article-title>The world health report 2002 - reducing risks, promoting healthy
life</article-title><source>Educ Health</source><year>2003</year><volume>16</volume><issue>2</issue><fpage>230</fpage><lpage>230</lpage></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azevedo e Silva</surname><given-names>G</given-names></name><name><surname>Valente</surname><given-names>JG</given-names></name><name><surname>Malta</surname><given-names>DC</given-names></name></person-group><article-title>Trends in smoking among the adult population in Brazilian
capitals: a data analysis of telephone surveys from 2006 to
2009</article-title><source>Rev Bras Epidemiol</source><year>2011</year><volume>14</volume><issue>Suppl 1</issue><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">22002147</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sepehripour</surname><given-names>AH</given-names></name><name><surname>Lo</surname><given-names>TT</given-names></name><name><surname>McCormack</surname><given-names>DJ</given-names></name><name><surname>Shipolini</surname><given-names>AR</given-names></name></person-group><article-title>Is there benefit in smoking cessation prior to cardiac
surgery?</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2012</year><volume>15</volume><issue>4</issue><fpage>726</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">22761116</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Centers for Disease Control and Prevention (CDC)</collab></person-group><article-title>Quitting smoking among adults: United States,
2001-2010</article-title><source>MMWR Morb Mortal Wkly Rep</source><year>2011</year><volume>60</volume><issue>44</issue><fpage>1513</fpage><lpage>1519</lpage><pub-id pub-id-type="pmid">22071589</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khullar</surname><given-names>D</given-names></name><name><surname>Maa</surname><given-names>J</given-names></name></person-group><article-title>The impact of smoking on surgical outcomes</article-title><source>J Am Coll Surg</source><year>2012</year><volume>215</volume><issue>3</issue><fpage>418</fpage><lpage>426</lpage><pub-id pub-id-type="pmid">22795477</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazzano</surname><given-names>LA</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Vupputuri</surname><given-names>S</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name></person-group><article-title>Relationship between cigarette smoking and novel risk factors for
cardiovascular disease in the United States</article-title><source>Ann Intern Med</source><year>2003</year><volume>138</volume><issue>11</issue><fpage>891</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">12779299</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levitzky</surname><given-names>YS</given-names></name><name><surname>Guo</surname><given-names>C-Y</given-names></name><name><surname>Rong</surname><given-names>J</given-names></name><name><surname>Larson</surname><given-names>MG</given-names></name><name><surname>Walter</surname><given-names>RE</given-names></name><name><surname>Keaney</surname><given-names>JF</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Relation of smoking status to a panel of inflammatory markers:
The Framingham offspring</article-title><source>Atherosclerosis</source><year>2008</year><volume>201</volume><issue>1</issue><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">18289552</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanbaeva</surname><given-names>DG</given-names></name><name><surname>Dentener</surname><given-names>MA</given-names></name><name><surname>Creutzberg</surname><given-names>EC</given-names></name><name><surname>Wesseling</surname><given-names>G</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name></person-group><article-title>Systemic effects of smoking</article-title><source>Chest</source><year>2007</year><volume>131</volume><issue>5</issue><fpage>1557</fpage><lpage>1566</lpage><pub-id pub-id-type="pmid">17494805</pub-id></element-citation></ref></ref-list></back></article>